スピノセレベラー・アタキアタイプ3におけるディサルトリア: 罹患率と疾患進行

Hai-Ping Ji¹, Mao-Lin Cui^1,2, Wei Lin¹

¹Department of Neurology, Fujian Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Journal of speech, language, and hearing research : JSLHR

|August 22, 2025

まとめ

疾患の持続期間が主な予測因子で,スピノセレベラーアタキシア3型 (SCA3) の患者の78%以上に影響します. 発話障害は8年経過すると大きく増加します

科学分野:

神経科学
遺伝学
臨床神経学

背景:

脊髄小胞性アタキシア3型 (SCA3) は,ATXN3遺伝子のCAG再発によって引き起こされる一般的な遺伝疾患である.
SCA3患者の生活の質に影響を与える一般的な症状です.
SCA3における難関症の流行と臨床的相関に関する研究は限られている.

研究の目的:

SCA3患者における発症率を調査する.
ディサルトリアに関連した臨床的特徴と疾患進行因子を特定する.
SCA3における疾患の持続時間と発症の関係を決定する.

主な方法:

183人のSCA3患者の遡及分析
患者は,SARAスピーチサブスケールスコアに基づいて,筋痛症と筋痛症でないグループに分けられた.
スピアマンの rho,ロジスティック回帰,カプラン-マイヤー曲線を含む統計分析.

主要な成果:

研究されたSCA3コホートでは,発症率は78. 7%であった.
発症した患者はSARAスコアが高く,発症期間が長かった.
疾患の持続期間は,脱筋関節症の最も強い予測因子 (r=0. 319, p<0. 001) と独立した予後因子であった.

結論:

SCA3では発症率が高く,疾患の持続時間と強く関連しています.
疾患の進行とともに,特に最初の10年後に発症率が上昇します.
SCA3患者にとって,特に病気が進行した段階で,早めに介入することが重要です.

さらに関連する動画

07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

36.2K

08:51

Cerebellar Regional Dissection for Molecular Analysis

Published on: December 5, 2020

4.9K

関連する概念動画

01:15

Parkinson's Disease: Overview

703

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

703

01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

01:24

Parkinson's Disease: Treatment

377

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

377

01:26

Alzheimer's Disease: Overview

666

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

666

01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...

関連する実験動画